Scientific & Medical Equipment House Co. reported a net profit after minorities of SAR 77.6 million for 2021, a 4% increase from SAR 74.8 million in the year-earlier period.
| Item | 2020 | 2021 | Change |
|---|---|---|---|
| Revenues | 617.48 | 699.45 | 13.3 % |
| Gross Income | 150.85 | 152.98 | 1.4 % |
| Operating Income | 88.06 | 83.42 | (5.3 %) |
| Net Income | 74.76 | 77.52 | 3.7 % |
| Average Shares | 30.00 | 30.00 | - |
| EPS (Riyals) | 2.49 | 2.58 | 3.7 % |
The profit rise was attributed to winning and commencing six new projects during 2021 with total contracts value of SAR 258.4 million, in addition to projects won and commenced at the end of 2020 and continued in 2021 with total value of SAR 267.4 million.
| Item | Q4 2020 | Q4 2021 | Change |
|---|
| Item | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Revenues | 176.51 | 205.30 | 16.3 % |
| Gross Income | 37.54 | 39.07 | 4.1 % |
| Operating Income | 19.21 | 17.52 | (8.8 %) |
| Net Income | 16.97 | 17.45 | 2.9 % |
| Average Shares | 30.00 | 30.00 | - |
| EPS (Riyals) | 0.57 | 0.58 | 2.9 % |
Shareholders’ equity, after minority interest, grew by 10.6% to SAR 473.458 million as of Dec. 31, 2021, from SAR 428.002 million a year earlier.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}